FDA Inspection 1203488 — BOLIVE INC

BOLIVE INC — FEI 3013074455

The FDA completed an inspection of BOLIVE INC on April 17, 2023 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 17, 2023
Fiscal Year
2023
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Los Angeles, CA (United States)

Additional Details

FSVP

Citations

IDCFRDescription
1826221 CFR 1.504(a)Hazard analysis written
1828121 CFR 1.505(a)(2)Evaluation - performance, risk
1829021 CFR 1.506(a)(1)Approved supplier procedures - importer established
1830321 CFR 1.506(e)(1)Verification activity before import, periodically
1832521 CFR 1.508(b)Investigate